Relation of amniotic fluid C-peptide levels to neonatal body composition. 1994

M A Krew, and R J Kehl, and A Thomas, and P M Catalano
Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, Ohio.

OBJECTIVE To compare the correlation between fetal insulin production (as estimated by amniotic fluid [AF] C-peptide concentration) and neonatal body fat (as estimated by both anthropometrics and total body electrical conductivity) with that between fetal insulin production and birth weight or fat-free mass. METHODS Amniotic fluid C-peptide concentration measured within 1 week of delivery was correlated with birth weight and neonatal body composition, estimated by both anthropometric measures and total body electrical conductivity within 24 hours of birth. Eighteen term neonates were studied: 13 from pregnancies complicated by diabetes and five from mothers with normal glucose tolerance. RESULTS Six infants were large for gestational age and 12 were appropriate for gestational age. There was a significant correlation between AF C-peptide level and neonatal fat mass, estimated by either anthropometric measures (r = 0.72, P = .0008) or total body electrical conductivity (r = 0.61, P = .008) methodology. The correlation was weaker between AF C-peptide level and either ponderal index (r = 0.44, P = .064) or total weight (r = 0.39, P = .11). The correlation with fat-free mass estimated by either method was not statistically significant. CONCLUSIONS Our results suggest that fetal insulin production, as estimated by AF C-peptide concentration, influences fetal growth primarily through increasing fetal fat deposition rather than lean body mass.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011254 Pregnancy in Diabetics The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy. Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic
D001724 Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms. Birthweight,Birth Weights,Birthweights,Weight, Birth,Weights, Birth
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D004553 Electric Conductivity The ability of a substrate to allow the passage of ELECTRONS. Electrical Conductivity,Conductivity, Electric,Conductivity, Electrical
D005260 Female Females

Related Publications

M A Krew, and R J Kehl, and A Thomas, and P M Catalano
April 1982, American journal of obstetrics and gynecology,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
December 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
January 1983, Biology of the neonate,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
January 1983, Ginekologia polska,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
May 1994, Zhonghua yi xue za zhi,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
July 1978, Indian pediatrics,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
June 1966, Clinical obstetrics and gynecology,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
January 1982, Nutrition reviews,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
November 1981, American journal of obstetrics and gynecology,
M A Krew, and R J Kehl, and A Thomas, and P M Catalano
November 1972, Obstetrics and gynecology,
Copied contents to your clipboard!